White Paper: The Global Use of Medicines: Outlook Through 2015

Spending is slow on medicines world wide for medicines within the next years due to the increased reliance on generic options in the United States.  Other causes for the decreased growth are sustained growth in emerging regions and government policies changing in various nations around the world.  The IMS Institute has a new white paper out looking at the effects of how spending worldwide will increase.

An excerpt from the white paper:
Spending on medicines will reach nearly $1,100Bn in 2015, reflecting a slowing growth rate of 3-6% over the five year period compared to 6.2% annual growth over the past five years.  Absolute global spending growth is expected to be $210-240Bn, compared to $251Bn since 2005.  The U.S. share of global spending will decline from 41% in 2005 to 31% in 2015, while the share of spending from the top 5 European countries will decline from 20% to 13% over the same period. Meanwhile, 17 high growth emerging markets led by China, will contribute 28% of total spending by 2015, up from only 12% in 2005.  The next five years will also see an accelerating shift in spending toward generics, rising to 39% of spending in 2015, up from 20% in 2005.

Download the white paper here.

Do you think this is true?  What role will specialized medicines for rarer diseases play in the coming years for medicine sales?

Share this article with your social network, just click below to share now!

Share |